Cross Atlantic Partners (CAP) actively manages private equity funds for investment in developing healthcare and life sciences companies in the United States. We focus on later-stage private and public companies developing innovative drug discovery t...Show all
Phone: 646-521-7500
551 Madison Ave
7th Floor
New York, 10022
New York, United States
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2013-09-20 | Labcyte | Series D - II | $0.48M | Abingworth, and Alloy Ventures |
2013-01-07 | Labcyte | Series D | $5.3M | Abingworth, Alloy Ventures, Delphi Ventures, GE Ventures, General Electric, and Tekla Capital Management |
2011-11-08 | Vitals | Series B - III | $12M | Activate Venture Partners, Cardinal Partners, and Health Venture Group |
2011-10-21 | Vitals | Series B - II | $3M | Activate Venture Partners, Cardinal Partners, and Health Venture Group |
2011-02-03 | Vitals | Series B | $16.32M | Activate Venture Partners, Greycroft, and Health Venture Group |